Navigation Links
New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
Date:6/18/2009

to find better tools and novel approaches to implement the requirements of regulations efficiently and cost effectively," says Dr. Suzanne Gagnon, Chief Medical Officer, ICON Clinical Research.

The report was commissioned by ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and developed by IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries.

Phase IV activities, including observational trials or "safety registries" that gather data on the use and effectiveness of medications in the real world are expected to be particularly impacted by new regulations, according to the survey. Eighty percent of respondents anticipate the number of Phase IV trials to grow over the next five years, while 58 percent indicated that safety registries increasingly will be used to monitor drug safety at every stage of the clinical trial process.

"The move toward greater transparency around drug safety remains a regulatory and political priority worldwide," says Nigel Burrows, Senior Principal, Management Consulting, IMS. "The pharmaceutical industry has and continues to respond to this challenge, both in drug clinical development and commercialisation. These efforts have the potential to go beyond simply satisfying regulatory requirements, leading to more clinically effective and commercially viable advances that improve outcomes and set new standards of care."

Notes to editors

Survey methodology

ICON commissioned IMS Health to conduct a survey that explored global trends in drug safety issues, and to evaluate the impact of recent safety regulations on the industry. A total of 140 people were questioned via a telephone interview, and included the heads of pharmacovigilance, safety and clinical research functions among pharmaceutical and biotechn
'/>"/>

SOURCE ICON plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
2. AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
3. Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre-Cancerous Barretts Esophagus
4. Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
5. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
6. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
7. New Study Suggests Rx Estrogen Delivery Through the Skin May Show Safety Benefits as Opposed to Oral Delivery
8. Results From Study Show Promising Efficacy and Safety Results for Cortheras Relaxin in Acute Heart Failure
9. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
10. RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009
11. Results From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 GenSpera, Inc. ... the treatment of cancer, announces the recent publication of ... Steroids . The recent article co-authored ... the evolution and development of GenSpera,s prodrug technology platform that ... thapsigargin (from the plant Thapsia garganica ) directly ...
(Date:8/28/2014)... MONROVIA, Calif. , Aug. 28, 2014  STAAR Surgical ... and marketer of implantable lenses and delivery systems for the ... 2014 Health Care Conference at the New York Palace Hotel ... Barry Caldwell , President and CEO will ... financial results, and operational developments and be joined by ...
(Date:8/28/2014)... -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL ... trials evaluating the use of collagenase clostridium histolyticum (CCH) for ... with a palpable cord will be presented at the upcoming ... Surgery of the Hand (ASSH) being held in ... (CCH) is a biologic approved in the U.S., EU, ...
Breaking Medicine Technology:GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 3STAAR Surgical To Present At The Baird 2014 Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 2Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 3Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 4Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 5Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting 6
(Date:8/28/2014)... Chicago, IL (PRWEB) August 28, 2014 ... Group, Inc., has been re-certified as a federal Patient ... authority of the Agency for Healthcare Research and Quality ... industry-leading patient safety expertise and services following the true ... (PSQIA) of 2005. , ”We are proud and eager ...
(Date:8/28/2014)... THURSDAY, Aug. 28, 2014 (HealthDay News) -- Having greater ... your ability to see distant objects in hazy conditions, ... University of Georgia researchers simulated hazy conditions in order ... levels of yellow pigment (also called macular pigment) in ... of yellow pigment, which represents accumulations of the nutrients ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 GreenRushReview.com, ... sector recently launched a “Video” section located at ... general information on various cannabis companies in video ... find an assortment of news clips, interviews, and ... announcements. A portion of the videos can also ...
(Date:8/28/2014)... On September 10, the Mesothelioma Applied Research ... president and CEO of Aduro BioTech, during a new ... live broadcast. The interview will be led by ... nurse practitioner, Mary Hesdorffer, APRN . , The ... therapy for malignant pleural mesothelioma, known as CRS-207. CRS-207 ...
(Date:8/28/2014)... August 28, 2014 PreDiabetes Centers, the ... of nutritious pizza recipes to help clients and online ... Day. PreDiabetes Concierge Chef Han Ashley developed variations of ... the Company’s website. , The PreDiabetes Centers Roasted Veggie ... pizza dough and features a cheese substitute–ideal for ...
Breaking Medicine News(10 mins):Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Eye Pigment May Help Vision in Hazy Conditions 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 3Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3Health News:PreDiabetes Centers Concierge Chef Creates Tasty Grilled Veggie Pizza Recipes for Labor Day Party Menu 2Health News:PreDiabetes Centers Concierge Chef Creates Tasty Grilled Veggie Pizza Recipes for Labor Day Party Menu 3
... Partnership to Focus on Energy Conservation and Facility Retrofitting ... July 23 Health Care Without Harm (HCWH) has entered into ... the William J. Clinton Foundation, to develop programs to help hospitals ... of carbon reduction. HCWH will work with CCI to develop ...
... A study led by researchers at the Ohio State ... how late-stage, hormone-independent prostate tumors gain the ability to ... hormone-independent growth marks an advanced and currently incurable stage ... 24, 2009, issue of the journal Cell , ...
... release is available in German . , The ... often overestimated. According to the German Institute for Quality and Efficiency ... travellers. When people wear a cast or splint after a sports ... have an increased risk of deep vein thrombosis in their leg ...
... , SOUTH SAN FRANCISCO, Calif., July 23 ... Company plans to host a conference call on Thursday, July 23, 2009 ... management team and the principal investigator of the trial will discuss results ... arthritis, the Company,s plans for further development and related matters. , ...
... ... heart function without need for cardiac stem cells , ... (Vocus) July 16, 2009 -- Injured heart tissue normally can,t regrow, ... heart tissue after a heart attack, in patients with heart failure, or in children with ...
... how ,plastic, these non-embryonic cells can be, experts say ... may be named "Tiny," but what it represents in ... According to Chinese researchers, the birth of Tiny (and ... Healthy, fertile animals grown using so-called pluripotent stem cells ...
Cached Medicine News:Health News:Health Care Without Harm Partners With Clinton Climate Initiative to Help Hospitals and Healthcare Facilities Reduce Environmental Impact 2Health News:Health Care Without Harm Partners With Clinton Climate Initiative to Help Hospitals and Healthcare Facilities Reduce Environmental Impact 3Health News:Scientists discover key event in prostate cancer progression 2Health News:The risk of developing deep vein thrombosis during a flight is often overestimated 2Health News:Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 2Health News:Study in this Week's Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 2Health News:Study in this Week's Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 3Health News:Scientists Use Adult Stem Cells to Create Healthy Mice 2Health News:Scientists Use Adult Stem Cells to Create Healthy Mice 3
... Stabilization with the Orthofix Pelvic Fixator is ... into the pelvis, and a fixator assembly ... by a connector unit. A supplementary link ... in iliac crest applications. With this new ...
The Pinless Fixator can be applied quickly and easily in the OR or ER to stabilize the fracture and soft tissues without invading the medullary canal, minimizing the risk of infection associated with...
The Adjustable Large Fixator is a one-piece fixator with a radiolucent body. It has a multifunctional design pivoting pin clamp for use in ankle or tibial plateau fractures....
The Small External Fixator has straight or angled frames, independent pin placement, and combines easily with Large and Medium External Fixator frames....
Medicine Products: